SCHEMBL5384197

SCHEMBL5384197

CSC(N)=NC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7274729 1.00
SCHEMBL1564703 1.00
SCHEMBL14062599 0.72
SCHEMBL11310902 0.72
SCHEMBL164048 0.71
SCHEMBL13493151 0.69
SCHEMBL12303963 0.69
SCHEMBL8179563 0.67
SCHEMBL12927244 0.67
SCHEMBL439990 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268455-A2 PIPERAZINE DERIVATIVES Pfizer Products Inc. (US) 2003-01-02 EP claimed
WO-2001072728-A9 NOVEL PIPERAZINE DERIVATIVES PFIZER PROD INC (US) 2002-10-10 WO claimed
WO-2001072728-A2 NOVEL PIPERAZINE DERIVATIVES PFIZER PRODUCTS INC. (US) 2001-10-04 WO claimed
JP-56015273-A None JP disclosed
WO-2025022310-A1 A METHOD FOR PREPARING 1-ALKYL-1H-1,2,4-TRAIZOL-3-AMINE COMPOUNDS PI INDUSTRIES LTD. (IN) 2025-01-30 WO disclosed
CN-107954999-B Oxadiazole ring-containing compound, preparation method, intermediate, composition and application 上海医药集团股份有限公司 2023-01-24 CN disclosed
WO-2017060641-A1 VETERINARY COMPOSITIONS FOR SANDFLY CONTROL CEVA SANTE ANIMALE (FR) 2017-04-13 WO disclosed
EP-2812323-B1 TETRAHYDRO-QUINAZOLINONE DERIVATIVES AS TANK AND PARP INHIBITORS MERCK PATENT GMBH (DE) 2016-04-06 EP disclosed
EP-2812323-A1 TETRAHYDRO-QUINAZOLINONE DERIVATIVES AS TANK AND PARP INHIBITORS Merck Patent GmbH (DE) 2014-12-17 EP disclosed
WO-2013117288-A1 TETRAHYDRO-QUINAZOLINONE DERIVATIVES AS TANK AND PARP INHIBITORS MERCK PATENT GMBH (DE) 2013-08-15 WO disclosed
US-7230132-B2 Aryl N-cyanoguanidines and methods related thereto MIGENIX CORP. (US) 2007-06-12 US disclosed
EP-0116769-A1 Dihydropyridines Pfizer Limited (GB) 1984-08-29 EP disclosed
EP-0074229-A1 Triazole gastric anti-secretory agents PFIZER INC. (US) 1983-03-16 EP disclosed
US-4352928-A ANTIINFLAMMATORY, HYPOGLYCEMIC, ANTICOAGULANT, ANOREXIGENIC, SEROTONIN EFFEC MITSUBISHI YUKA PHARMACEUTICAL CO., LTD. (JP) 1982-10-05 US disclosed
EP-0059903-A1 Diaminooxadiazoles, their use as gastric secretion inhibitors, and process for their preparation MERCK & CO. INC. (US) 1982-09-15 EP disclosed
EP-0059903-A1 Diaminooxadiazoles, their use as gastric secretion inhibitors, and process for their preparation MERCK & CO. INC. (US) 1982-09-15 EP disclosed
US-4332822-A HYPOTENSIVE AGENTS, ANTIULCER AGENTS JOHN WYETH & BROTHER LIMITED (GB) 1982-06-01 US disclosed
JP-S5615273-A PREPARATION OF PYRIMIDINE DERIVATIVE MITSUBISHI YUKA YAKUHIN KK 1981-02-14 JP disclosed
US-4250109-A FROM HEXAMETHYLENEDIAMINE AND AN N-CYANO-O (OR S)-ALKYL-ISO (OR ISOTHIO)UREA SOGO PHARMACEUTICAL COMPANY LIMITED (JP) 1981-02-10 US disclosed
EP-0022481-A1 5,6-Alkylenepyrimidine derivatives, processes for preparing the same and pharmaceutical compositions Mitsubishi Yuka Pharmaceutical Co., Ltd. (JP) 1981-01-21 EP disclosed